Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemiaTibor Kovacsovics, Paul J. Shami, Alice S. Mims et al.|Blood Advances|2018Cited by 59
CX-01, a Low Anticoagulant Heparin, May Enhance Count Recovery and Treatment Efficacy in Acute Myeloid LeukemiaTibor Kovacsovics, Paul J. Shami, Alice S. Mims et al.|Blood|2016Cited by 4
O-desulfated heparin and chemotherapy for the treatment of AML.Tibor Kovacsovics, Paul J. Shami, Alice S. Mims et al.|Journal of Clinical Oncology|2015Cited by 3
Preliminary Evidence That ODSH (2-O, 3-O Desulfated Heparin) Is Safe and Enhances Count Recovery in Patients Treated with Intensive Therapy for Acute Myeloid Leukemia – Results of a Pilot StudyTibor Kovacsovics, Paul J. Shami, Alice S. Mims et al.|Blood|2014Cited by 1
TIP-15. Trial in progress: phase IB study of concurrent Azeliragon, a RAGE inhibitor, with craniospinal irradiation in patients with leptomeningeal metastasesK.M. Banson, Jonathan T. Yang, Judith D. Goldberg et al.|Neuro-Oncology|2025Cited by 0